跳至主要内容
临床试验/NCT01589835
NCT01589835已完成2 期

Preventing Diabetes With Facilitated Lifestyle Intervention Prescriptions.Phase 2: Pilot Study

University of British Columbia1 个研究点 分布在 1 个国家目标入组 59 人开始时间: 2012年7月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
59
试验地点
1
主要终点
HbA1c Progression to diabetes

研究概览

简要总结

Nearly six million Canadians are living with an increased risk of diabetes (prediabetes) and approximately 50% of these will develop type 2 diabetes within five years. The investigators wish to help these people change their lifestyle, to prevent them from getting diabetes. Trials have shown that by supporting people with prediabetes to be more active and have healthier eating habits they can halve their risk. However, these interventions were very costly and not performed in Canada. With the help of local Family Physicians and other health professionals (e.g. physiotherapy, psychology, endocrinology, nursing) the investigators have created a less expensive intervention suitable for the Canadian population and health system. The investigators need to perform a study to see whether these modified approaches are practical for Canadians and likely to be effective. People at risk will be invited to participate from family practices that have helped us in the initial stages of this program. Family practices will be randomized to giving either the study intervention or continue with the physician's usual care. People receiving the intervention will have an appointment with their family doctor to discuss their exercise and eating habits and agree changes that are necessary. A prescription detailing these changes will be completed and signed by the family physician and participant. Participants will be given the name of a lifestyle change facilitator (LCF) who will receive a copy of the prescription and contact the participant to help them set achievable goals. The LCF will contact participants once a month for six months to help them achieve these goals. The investigators eventual aim is to test this intervention in a large-scale randomized control trial. To achieve this it is necessary to pilot all aspects of the trial. Information from the pilot study can then be used to design and perform a large-scale study effectively. The investigators hope that eventually the numbers of Canadians progressing to having diabetes will be reduced.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adults aged ≥ 18 years
  • •HbA1c of 5.7 to 6.4% and/or FPG of 6.1 to 6.9 mmol/l and/or a 2hr 75g OGTT of between 7.8 and 11.0 mmol/l

排除标准

  • •People with Type I or II diabetes
  • •Unstable angina
  • •Uncontrolled congestive heart failure
  • •Unstable arrhythmia
  • •Heart valvular disease
  • •Severe hypertension (systolic ≥ 200 or diastolic ≥ 120)
  • •Pregnant women or planning pregnancy within two years
  • •Life expectancy < 1 year
  • •Waiting for major surgery
  • •High risk of fracture
  • •Pregnancy or planning pregnancy

研究组 & 干预措施

Lifestyle counseling

Experimental

Green prescription with facilitator support

干预措施: Lifestyle changes (Behavioral)

Usual care

Other

干预措施: Lifestyle changes (Behavioral)

结局指标

主要结局

HbA1c Progression to diabetes

时间窗: 6 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验